PARIS, February 14 /PRNewswire/ --

- GenOdyssee has Received Notice of Allowance of United States Patent Application Covering it's Lead HCV Interferon-Alpha Product GEA007.1, a Natural Protein With Improved Anti-HCV Genotype 1 Activity

LONDON, February 14 /PRNewswire/ -- Saipem S.A and investment partnerships affiliated with Hellman & Friedman LLC ("H&F"), executed a definitive agreement under which H&F will acquire Saipem's 30% ownership stake in Gaztransport & Technigaz S.A.S. ("GTT") for EUR310 million. GTT is the leading marine engineering company operating in the liquefied natural gas ("LNG") sector and is based near Paris in Saint-Remy-les-Chevreuse and has over 200 employees.

Insects will feast and leafy plants will suffer if temperatures warm and atmospheric carbon dioxide increases, according to a team of researchers who studied evidence of insect feeding on fossil leaves from before, during and after the Paleocene-Eocene Thermal Maximum.

The PETM occurred 55.8 million years ago and was an abrupt global warming event linked to a temporary increase in carbon dioxide in the atmosphere. This event is comparable in size and rate to the current climate changes brought on by human activity.

PARIS, February 14 /PRNewswire/ -- Sanofi-aventis announced today that the Chicago Athenaeum Museum of Architecture and Design has awarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposable insulin injection pen for people with type 1 and type 2 diabetes.

"LANTUS(R) SoloSTAR(R) and APIDRA(R) SoloSTAR(R), the results of over four years of intensive development, have been designed in dialogue with patients, nurses and doctors and meet the high standards of the industry," said Paul Jansen, Global Head Medical Devices, sanofi-aventis.

"We are proud to receive this prestigious GOOD DESIGN Award for SoloSTAR(R) as a recognition of our strong commitment to people with diabetes", Gilles Lhernould, Senior Vice President Industrial Affairs sanofi-aventis added.

ARNHEM, The Netherlands, February 14 /PRNewswire/ -- The 23rd Annual Congress of the European Association of Urology will be held from 26-29 March 2008 in Milan, Italy. About 12,000 participants from some 100 different countries are expected to attend, which makes this event the second largest of its kind worldwide. And as media representative you cannot miss out. Why not? Please read on.

Scientific content

Results from field research supported by Earthwatch, the international environmental charity, will help scientists predict threats to wildlife should climate change result in a sea level rise in the Baltic.

During the six year research programme, coordinated by Earthwatch scientists Drs. Chris Joyce and Niall Burnside (University of Brighton), and Elle Puurmann (NGO Läänerannik), monitoring stations were installed in Vormsi Island, Silma Nature Reserve and Matsalu National Park, some of the best coastal wetlands in Estonia for nature conservation. The stations’ data loggers recorded water levels and soil moisture. Bird life was also recorded at fixed locations.

HEIDELBERG, Germany, February 14 /PRNewswire/ -- SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard), today announced that it has received a positive recommendation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) for AX200 for the treatment of Amyotrophic Lateral Sclerosis (ALS).

NEW YORK, February 14 /PRNewswire/ --

- New Study Finds Use of the Internet Now Dominates Quantitative Research Worldwide

Three out of five market research studies -- 60 percent of those fielded in the US and abroad -- were conducted online last year, according to the 2007 Medefield Pharmaceutical Market Research Trends Study.

The report, released today, indicates that Internet-based market Research -- once the orphan of the industry -- is now conducted three times more often than telephone interviews and nearly four times as often as those performed face-to-face, making online research the undisputed leader in methodology for quantitative physician studies.

PHNOM PENH, Cambodia, February 14 /PRNewswire/ --

MOBILE WORLD CONGRESS, BARCELONA, February 14 /PRNewswire/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced an agreement for Alcatel-Lucent to support the expansion of AT&T's UMTS/HSPA (Universal Mobile Telecommunications Service/High Speed Packet Access) wireless network. The expansion includes the deployment of Alcatel-Lucent's UMTS/HSDPA Distributed NodeB solution, which provides operators with the flexibility to deploy third-generation (3G) radio network elements in a wide array of locations including the sides of buildings, existing cell sites, remote locations and more, helping operators build out their networks more quickly and cost-effectively.